Alliance for Substance Abuse Progress


The COVID-19 Crisis Has Brought Substance Abuse to Light

October 2, 2021 By Theresa Agovino

The COVID-19 pandemic began to push conversations about SUDs into the open as drug and alcohol use, along with deaths from overdoses, soared. Loneliness, confusion and unemployment caused more people to either start using or increase their use of drugs or alcohol at a time when treatment centers and support groups were shuttered due to the public health crisis.


How the Pandemic Led to the Rise of Virtual Rehab

October 2, 2021 By HealthLine

The global pandemic has meant a major shift in medical care with more physicians and patients turning to telemedicine for treatment of non-urgent conditions.

In the last 18 months, telemedicine has been used for much more than simple check-ins with the primary care physician, it’s now being used to help with addiction treatment via virtual rehabs.


IU looks to expand program that trains Hoosiers to respond to overdose events

October 1, 2021 By Mitch Legan

IU Prevention Insights’ “Overdose Rapid Response System” is educating Hoosiers from five counties about opioid overdoses and how to respond to them. Launched last September, the program trains people how to administer the opioid antidote Naloxone – also known by the brand name Narcan – and connects them to possible overdose events in their area.


What is Narcan and how do you use it?

September 22, 2021 By Kelsey Weekman

Narcan, also known as Naloxone, is a nasal spray that can combat the life-threatening effects of an opioid overdose.


Pharmacists Can Help Address the Stigma Around Substance Abuse

September 22, 2021 By Ashley Gallagher

Thomas Menighan, co-founder of PursueCare and the CEO Emeritus of the American Pharmacists Association, discussed National Recovery Month, substance use disorder and a pharmacist’s role in helping those struggling with addiction understand what treatments are available and find the best options for them.


The AMA’s 7 Recommendations for Reducing the Opioid Crisis

September 21, 2021 By Leah Kuntz

“Policymakers and other stakeholders have a choice of whether to pursue evidence-based strategies to support patients’ access to lifesaving and life- affirming care. Every effort must be made to remove health inequities and other barriers for patients with substance use disorders, mental illness and patients with pain. More of our loved ones will suffer and die if these barriers remain,” said Bobby Mukkamala, MD, Chair of the AMA Substance Use and Pain Care Task Force.


ASAP, Centerstone holding wellness event Friday

September 17, 2021 By WKKG

ASAP and Centerstone are joining together to hold a Community Wellness Event from 5 to 8 next Friday at the Doug Otto United Way Center

The wellness event is being held in conjunction with National Recovery Month. It will feature recovery resources, employment opportunities, harm reduction information, prevention materials, testing for HIV, AIDS and HEP-C, recovery coaching, and more.


Opioid Overdose Deaths Are Comparable To Heart Attacks

September 17, 2021 By Nu Herald

“For heart attacks, hospital systems across the U.S. have universally accepted standards, metrics, and quality reporting that drives performance,” said Honora Englander, M.D. “The same should be true for opioid use disorder, where death rates are similar.”


A Vaccine to Treat Opioid Disorders: First Participant Enrolled in Trial

September 15, 2021 By Leah Kuntz

A clinical trial studying a vaccine for opioid use disorder developed by University of Minnesota Medical School researchers has enrolled its first participants. The phase 1 randomized placebo-controlled trial, funded by a grant from the National Institutes of Health, will test the safety and potential efficacy of a vaccine that could prevent both the euphoric and toxic effects of oxycodone.


Black Americans dying from opioid overdoses at a faster rate than whites, report says

September 10, 2021 By Josh Marcus

The rate of opioid overdose deaths has been climbing faster for African-Americans than other groups, a study from the National Institute of Health’s National Institute on Drug Abuse (NIDA) found, in findings published on Thursday.